Affordable Access

deepdyve-link deepdyve-link
Publisher Website

An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.

Authors
Type
Published Article
Journal
European Journal of Gastroenterology & Hepatology
0954-691X
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
20
Issue
6
Pages
506–511
Identifiers
DOI: 10.1097/MEG.0b013e3282f3e6f5
PMID: 18467909
Source
Medline
License
Unknown

Abstract

A total of 55% of the patients with cirrhosis had MHE. Lactulose or probiotics or combinations of both are equally effective in the treatment of MHE.

Statistics

Seen <100 times